Carglumic acid treats hyperammonemia by interacting with the NAGS gene, compensating for deficiencies in N-acetylglutamate synthase caused by mutations in this gene. This action assists in activating carbamoyl phosphate synthetase 1 (CPS1), facilitating ammonia detoxification in the urea cycle.